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https://doi.org/10.1016/j.celrep.2020.108404SUMMARYStressful experiences early in life can increase the risk of cardiovascular diseases. However, it remains largely
unknown how stress influences susceptibility to the disease onset. Here, we show that exposure to brain-
processed stress disrupts myocardial growth by reducing cardiomyocyte mitotic activity. Activation of the
glucocorticoid receptor (GR), the primary stress response pathway, reduces cardiomyocyte numbers, dis-
rupts trabecular formation, and leads to contractile dysfunction of the developing myocardium. However,
a physiological level of GR signaling is required to prevent cardiomyocyte hyperproliferation. Mechanisti-
cally, we identify an antagonistic interaction between the GR and the cytokine interleukin-4 (IL-4) as a key
player in cardiac development. IL-4 signals transcription of key regulators of cell-cycle progression in cardi-
omyocytes via signal transducer and activator of transcription 3 (Stat3). GR, on the contrary, inhibits this
signaling system. Thus, our findings uncover an interplay between stress and immune signaling pathways
critical to orchestrating physiological growth of the heart.INTRODUCTION
Substantial evidence suggests a strong association between
early-life adversity and cardiovascular disease in adulthood
(Kivimäki and Steptoe, 2018; Suglia et al., 2018). It has been
proposed that early-life interventions targeting stress regulatory
pathways may be more effective than treating downstream car-
diovascular impairments after disease onset (Suglia et al., 2018).
However, little is known about the causative role and mecha-
nisms by which stress in early life affects the phenotypes of
the cardiovascular system later.
In vertebrates, behavioral and physiological responses to
stress are mainly orchestrated by the hypothalamus-pituitary-
adrenal (HPA) axis (Chrousos and Gold, 1992). Within minutes
of exposure to stressors, specialized hypothalamic neurons
release the peptide corticotropin-releasing hormone (CRH) in
the pituitary. Subsequent secretion of adrenocorticotropic
hormone (ACTH) from the pituitary stimulates adrenal cortex
production of glucocorticoids (GCs), the primary mediators of
stress-responsive homeostasis in various organs (Chrousos
and Gold, 1992; Sapolsky et al., 2000). The ability of GCs to alter
neuroendocrine balance, metabolism, sympathetic activity, and
immune function implies that systemic maladaptation to stress
might underlie an increased susceptibility of the cardiovascular
system to pathological onset (Kivimäki and Steptoe, 2018; Sap-
olsky et al., 2000; Suglia et al., 2018). Chronic inflammation, forCe
This is an open access article under the CC BY-Nexample, has been reported in adults experiencing adversities
in their childhood (Danese et al., 2007; Hostinar et al., 2015).
However, HPA axis activation and GC production are strictly
regulated by negative-feedback mechanisms to assure tempo-
rally restricted responses (Gjerstad et al., 2018; Osterlund
et al., 2016), raising the question of how their effects persist
into adulthood. Different hypotheses that have been proposed
to explain the link between fetal exposure to excess GCs and
increased risk for cardiovascular diseases later in life are based
on indirect effects of stress on cardiac function (Braun et al.,
2013; Tegethoff et al., 2009). Chronic elevation of blood pressure
and other endocrine dysfunctions are among themajor suspects
to underlie adverse cardiometabolic events caused by modifica-
tion of HPA axis functions (Braun et al., 2013; Tegethoff et al.,
2009). Alternatively, other models link early-life stress to cardio-
vascular diseases through an intermediate role of stress-induced
mental conditions, such as depression (Suglia et al., 2018). How-
ever, evidence demonstrating a causal relationship between
early-life stress, and resulting behavioral or chronic hormonal
disorders, and the irreversible maladaptation predisposing indi-
viduals to cardiovascular illness in adulthood is still lacking.
Although it was shown that GCs can alter the maturation of car-
diomyocytes (CMs) (Oakley et al., 2013; Rog-Zielinska et al., 2015;
Wilson et al., 2015), involvement of early-life stress signaling dur-
ing development of the heart andmolecular mechanisms underly-
ing its actions are poorly understood. Here, we used physical,ll Reports 33, 108404, November 17, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Exposure to Stress or Elevated GCs
Reduces CM Proliferation, Lowers the Total
Number of CMs, Impairs Trabeculation, and
Attenuates Ventricular Contractility
(A) Scheme showing the timeline of vibrational
stress application.
(B) The 5-dpf Tg(myl7:H2B-GFP)zf521 larval hearts
after application of vibrational stress or control
treatment, immunostained for the proliferation
marker PCNA and GFP.
(C) Bar graph depicting the average percentage of
PCNA-positive (PCNA+) CMs in control and shaken
(stressed) larvae.
(D) Schematic representation of the timeline for dex
application.
(E) The 5-dpf Tg(myl7:H2B-GFP)zf521; Tg(myl7:
mKate-CAAX)sd11 control and dex-treated hearts.
(F and G) Graphs depicting average CM number
(F) and ventricle volume (G) of control and dex-
treated 5-dpf Tg(myl7:H2B-GFP)zf521; Tg(myl7:
mKate-CAAX)sd11 larvae.
(H) The 5-dpf Tg(myl7:H2B-GFP)zf521; Tg(myl7:
mKate-CAAX)sd11 hearts showing a reduced num-
ber of trabeculae (arrows) upon dex treatment.
(I) Graph showing reduced ratio of trabecular/
compact wall CM numbers in dex-treated larvae
compared to controls.
(J and K) Bar graphs showing diastolic (J) or systolic
(K) speed of 5-dpf larval hearts treated with dex and
controls.
Data are presented as mean ± SEM. *p < 0.05, **p <
0.01, t test. n indicates number of larvae used for
experiments. See also Figures S1–S3.
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signaling to test whether brain-mediated stress could directly in-
fluence the cardiac developmental program, resulting in early
morphological and functional alterations of the heart. To this
end, we exploited zebrafish to overcome the intrinsic difficulties
related to experimental application of stressors in animals that
develop in utero. We focused our attention on pre-hatching (2 to
3 days post-fertilization [dpf]) and early post-hatching periods
(4 to 5 dpf) of zebrafish, when developmental stages of the heart
are similar to late-gestational/early-postnatal ones in mammals.
We revealed that stress negatively affects mitotic activity of
CMs in the developing heart by affecting the transcription of key
cell-cycle regulators. Importantly, we identified a stress-cytokine
signaling interaction, in which GR counteracts pro-mitotic action
of interleukin-4 (IL-4), to serve as an important regulator of
myocardial growth. Together, our results uncover a role of stress
signaling in cardiac development, reveal a non-immune signaling
function of a cytokine, and identify an antagonistic interaction be-
tween these pathways in CMs.2 Cell Reports 33, 108404, November 17, 2020RESULTS
Early-Life Stress Impairs CM
Proliferation
First, to examinewhether the cardiacdevel-
opmental program is affected by brain-
mediated stress triggered by a physicalchallenge experienced during early life, we exposed 4-dpf zebra-
fish larvae to a vibrational stimulus causing water shaking for 16 h
(Figure 1A). This type of stimulus was previously employed to
model a brain-mediated stress response in zebrafish larvae (Cas-
tillo-Ramı́rez et al., 2019). Interestingly, following this short-term
exposure to the stressor, we observed a reduction of CM prolifer-
ation. In Tg(myl7:H2B-GFP)zf521 larvae, in which CM nuclei were
fluorescently marked by histone-H2B-tagged GFP (H2B-GFP;
Figure 1B), a decreased mitotic rate was detectable by immuno-
staining of proliferating cell nuclear antigen (PCNA), labeling
nuclei of cells in the G1-S phase (Figures 1B and 1C). Thus, a
physical challenge inducing brain-processed stress causes an
anti-mitotic response in CMs during cardiac morphogenesis.
Activation of the GR Reduces CM Numbers, Disrupts
Trabeculation, and Impairs Contractility of the
Developing Myocardium
HPA-axis-induced GC production activates diverse cellular
responses to stress by binding to the GR. While GCs are key
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be unrelated to stress response. On the other hand, stress
response could be GR independent (MacDougall-Shackleton
et al., 2019). To test whether brain-mediated stress imposes its
developmental perturbation effect on the heart through GR acti-
vation, we used the potent GR agonist dexamethasone (dex).
Physiologically, embryos of placental mammals are exposed to
negligible levels of GCs, but endogenous GCs rise rapidly at
late gestation (Fowden et al., 1998; Rog-Zielinska et al., 2015).
Therefore, we chose to examine the effect of dex from 2 dpf in
zebrafish to recapitulate the late gestation developmental stage
of the heart (Andrés-Delgado and Mercader, 2016).
Upon 3-day dex treatment from 2 dpf to 5 dpf (Figure 1D), the
cardiac ventricle contained fewer CMs, as observed from the
expression of nuclear GFP and membrane mKate in CMs of
Tg(myl7:H2B-GFP)zf521; Tg(myl7:mKate-CAAX)sd11 larvae (Fig-
ures 1E and 1F). The reduction of CM number was not a result
of increased cell death. As in control siblings, dex-treated larvae
showed a negligible number of CMs undergoing apoptosis (Fig-
ure S1A). Further examination of the ventricular wall revealed
eccentric hypertrophy, characterized by increased ventricular
volume (Figures 1E and 1G) and caused at least in part by hyper-
trophic growth of CMs (Figure S1B). Trabeculation—a critical
developmental process closely associatedwith CMproliferation,
which allows an increase of muscle mass for proper contractile
function—was disrupted by dex treatment (Figures 1H and 1I).
By contrast, development of the endocardium and epicardium
was not affected by dex treatment (Figures S2A–S2D), suggest-
ing that the action of GC signaling in the developing heart is
restricted to the myocardium. As a consequence of myocardial
morphological alterations, dex-treated hearts displayed attenu-
ated functionality, as evidenced by reduced diastolic and sys-
tolic speed (Figures 1J and 1K; Videos S1 and S2). No significant
reduction of ejection fraction or fractional shortening was
observed following 3-day dex treatment (Figures S3A and
S3B), suggesting that the dex-induced reduction of CMnumbers
might not be associated with myocardial stiffening, a common
hallmark of the transition from compensated hypertrophy to
heart failure (Makarenko et al., 2004). Taken together, these
data suggest that stress influences heart development through
the anti-proliferative action of the GR in CMs, leading to adverse
morphological and functional alteration of the myocardium.
IL-4 Signaling Regulates CM Mitosis during
Development
Upon binding to the GR, GCs induce pleiotropic effects on
various cell types by direct binding to DNA via GC response
element or interaction with other transcription factors to regulate
gene transcription (Cain and Cidlowski, 2017). One of the most
widely appreciated roles of GCs is their potent immune suppres-
sive property. Crosstalk between GCs and immunomodulatory
pathways such as pattern recognition and cytokine signaling
underlies the ability of GCs to promote inflammatory resolution
and inhibit leukocyte activation (Cain and Cidlowski, 2017). In
addition, expression of different cytokines—including IL-4,
IL-6, IL-17, and interferon (IFN)g—in certain immune cell types
is regulated by GCs (Cain and Cidlowski, 2017). Moreover,
phenotypical and functional alterations of immune cells havebeen proposed to underlie adverse cardiovascular remodeling
(Swirski and Nahrendorf, 2018). For these reasons, we hypothe-
sized that dysregulation of immune pathways by excessive
GR activation might mediate the effect of stress on morpholog-
ical and functional remodeling of the developing heart. In search
of a potential mediator of GR-immune crosstalk in the heart, we
first focused on cytokine signaling. In situ hybridization showed
that a cognate receptor of the signature cytokine of the type II
inflammatory response, IL-4 receptor (IL-4r), was expressed in
CMs of the developing zebrafish heart as early as 3 dpf (Fig-
ure S4A). We could not detect il4 mRNA in the heart, but it was
prominently expressed at a close proximity in the thymus, a he-
matopoietic organ (Figures S4B and S4C), suggesting that as in
mammals, IL-4 is mainly produced by immune cells also in ze-
brafish larvae. We also examined expression of the principal
type I pro-inflammatory cytokine IFNg and its receptor but found
them to be undetectable in the myocardium (Figures S4D and
S4E). Interestingly, IL-4 abundance was reported to be inversely
correlated with anxiety (Hou et al., 2017), a mental condition
associated with stress. Cardiac tissue expression and relation
to stress of this cytokine/receptor system prompted us to
examine further its role in cardiac development and crosstalk
with GR signaling.
First, we generated the transgenic line Tg(hsp70:il4-6xHIS)md74
that enables heat-inducible expression of 6xHIS-tagged IL-4 (il4-
6xHIS) under control of the 70 kilodalton heat shock protein
(hsp70) promoter (Figure 2A). To understand the effect of exces-
sive IL-4 production in the developing heart, we examined
Tg(hsp70:il4-6xHIS)md74; Tg(myl7:H2B-GFP)zf521; Tg(myl7:mKate-
CAAX)sd11 larvae following heat induction of il4-6xHIS overexpres-
sion daily from 1 to 5 dpf (Figure 2B). Larvae exposed to elevated
IL-4 levels showed a higher number of ventricular CMs and
increased ventricular volume (Figures 2C–2E). Formation of the
trabecular layer was not altered by IL-4 induction, as shown by
comparable ratios of trabecular/compact wall CMs (Figures 2F
and 2G). Development of the endocardium and the epicardium
was also not affected (Figures S2E–S2H). The overgrowth of the
heart was associated with increased diastolic and systolic speed
(Figures 2H and 2I; Videos S3 and S4) but did not alter ejection
fraction and fractional shortening (Figures S3C and S3D). Thus,
morphological and functional characterizations indicate that
supplemental CMs observed upon il4-6xHIS overexpression
integrated normally into the myocardium and improved cardiac
contractility.
Our findings on IL-4 induction of myocardial overgrowth
prompted further investigation of the requirement of IL-4
signaling to regulate CM mitotic rate. To this end, we assessed
proliferation rate of 5-dpf Tg(myl7:H2B-GFP)zf521 larvae at 16 h
following pericardial injection of an IL-4-neutralizing antibody
(Figure 2J), previously shown to efficiently antagonize IL-4 action
in zebrafish (Bhattarai et al., 2016). PCNA immunohistochemistry
showed that IL-4 deficiency caused a reduction of CM prolifera-
tion in 5-dpf larvae, compared to siblings injected with control
antibody against a 6-histidine epitope (Figures 2K and 2L).
Taken together, these gain- and loss-of-function approaches
identify a previously unknown function of the cytokine IL-4 as
an indispensable regulator for cardiac development through
the control of CM proliferation.Cell Reports 33, 108404, November 17, 2020 3
Figure 2. IL-4 Induces Myocardial Growth
and Improves Ventricular Contractile Func-
tion
(A) Scheme of the hsp70:il4-6xHIS transgenic
construct.
(B) Diagram illustrating design of the il4-6xHis
overexpression experiment.
(C) Hearts of 5-dpf control Tg(myl7:H2B-GFP)zf521;
Tg(myl7:mKate-CAAX)sd11 and il4-6xHis-over-
expressing Tg(hsp70:il4-6xHIS)md74; Tg(myl7:H2B-
GFP)zf521; Tg(myl7:mKate-CAAX)sd11 larvae. CM
nuclei and membranes are labeled with H2B-GFP
and mKate-CAAX, respectively.
(D and E) Bar graphs showing average ventricle CM
number (D) and ventricle volume (E) of control and
il4-6xHis-overexpressing 5-dpf larvae.
(F) Normal formation of trabeculae (arrows) in 5-dpf
control and il4-6xHis-overexpressing Tg(myl7:H2B-
GFP)zf521; Tg(myl7:mKate-CAAX)sd11 larvae.
(G) Bar graph showing similar ratios of trabecular/
compact wall CM numbers in il4-6xHIS-over-
expressing and control larvae.
(H and I) Bar graphs displaying average diastolic
(H) and systolic (I) speeds of 5-dpf Tg(hsp70:
il4-6xHIS)md74; Tg(myl7:H2B-GFP)zf521; Tg(myl7:
mKate-CAAX)sd11 larval hearts.
(J) Scheme of the loss-of-function experiment
design.
(K) The 5-dpf Tg(myl7:H2B-GFP)zf521 hearts of
larvae injected with antibody against IL-4 (il4-nAB)
or against 6x-His repetitive sequence as control.
(L) Bar graph depicting average percentage of
PCNA-positive (PCNA+) CMs in 5-dpf Tg(myl7:H2B-
GFP)zf521 larvae injected with IL-4-nAB and control
antibodies.
Data are presented as mean ± SEM. *p < 0.05, **p <
0.01, n.s., not significant, t test. n indicates number




OPEN ACCESSGC Interacts with IL-4 Signaling Pathway Independently
of il4 or il4r Transcriptional Control
To test whether GC and IL-4 signaling pathways interact with
each other to regulate heart development, we performed
PCNA analysis to assess CM proliferation in Tg(myl7:H2B-
GFP)zf521 larvae exposed to combinatorial manipulations of
both pathways (Figures 3A–3C). Consistent with our finding of
an anti-mitotic effect of stress (Figures 1B and 1C), 6 h of dex
exposure reduced ventricular CM proliferation in 5-dpf larvae
(Figures 3B and 3C). Having shown that GCs act as a CMmitotic
brake, we next askedwhether GC signaling onlymediates devel-
opmental adaptation of the heart in response to stress or if it
might play a role in physiological growth. Intriguingly, contrary
to the mitotic suppression in response to GR activation, GR inhi-
bition by 6 h of treatment with the drug mifepristone (mif) was
able to drive a higher percentage of CMs into the cell cycle
compared to control siblings (Figures 3B and 3C). Similarly, we
observed an increase of CM proliferation at 6 h after induction
of il4-6xHIS expression (Figures 3B and 3C), further supporting
the pro-mitotic role of IL-4. Importantly, dex-mediated GR acti-
vation abolished the effect of il4-6xHIS overexpression (Figures4 Cell Reports 33, 108404, November 17, 20203B and 3C), indicating the interaction between the two path-
ways. Similar responses to activation of IL-4 and GR pathways
were also observed in atrial CMs, indicating that the role of
IL-4-GR signaling interaction as a proliferative regulator is not
limited to the ventricle (Figure S5).
Since GCs can inhibit the transcription of various cytokines
(Cain and Cidlowski, 2017), we next tested whether suppression
of il4 or il4r expressionmight underlie the antagonistic interaction
between the GR and IL-4 pathways. However, qPCR analyses
showed that GR activation by dex treatment did not alter levels
of whole-body il4 mRNA and cardiac IL-4 receptor complex
il4r, il13ra1, and il13a2 mRNAs (Figure 4A). These observations
indicate that GR regulates CM proliferation by a different mech-
anism involving interaction with IL-4 downstream signaling.
GCs and IL-4 Act Upstream of Stat3 to Balance Mitotic
Activity in CMs
A key mediator of IL-4 signaling is the transcription factor Stat6
(Kelly-Welch et al., 2005). IL-4 binding to the IL-4r leads to
Stat6 activation and subsequent expression of several IL-4
target genes. To gain further mechanistic insight into how GCs
Figure 3. GR and IL-4 Signaling Interact to
Regulate Cardiac Development
(A) Schemes showing timeline of drug treatment
(red bars) and heat induction of il4-6xHis expression
(blue bars).
(B) Images of 5-dpf Tg(myl7:H2B-GFP)zf521 cardiac
ventricles following control treatment (control), dex
treatment (dex) and mif-treatment (mif), or
Tg(hsp70:il4-6xHIS)md74; Tg(myl7:H2B-GFP)zf521
hearts after il4-6xHis overexpression (IL-4-6xHis)
and simultaneous il4-6xHis overexpression and
dex treatment (IL-4-6xHis + dex), stained with
antibodies against PCNA and GFP.
(C) Bar graph depicting average percentage
of PCNA+ ventricular CMs in 5-dpf larvae exposed
to different combinations of il4-6xHis over-
expression and GR signaling inhibition (mif) or
activation (dex).
Data are presented asmean ±SEM. *p < 0.05, ***p <
0.001, t test. n indicates number of larvae used for
experiments. See also Figure S5.
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whether the expression of Stat6 transcriptional targets involved
in cell division is altered in the developing heart upon IL-4 and
GC signaling activation. While the Stat6 target genes bcl2l1
and socs1a were readily upregulated at 2 h after il4-6xHis over-
expression, their expression was unaltered by dex-induced GR
activation (Figures 4B and 4C). Thus, we next examined the
expression of genes controlled by the transcription factor
Stat3, also activated by IL-4 (Rahaman et al., 2005). In agree-
ment with the antagonistic effect of GCs and IL-4 in CM prolifer-
ation (Figure 3C), 2 h of dex treatment reduced, while il4-6xHis
overexpression increased, expression of the Stat3-targeted
pro-mitotic genes c-myc and cyclind1 in the cardiac tissue (Fig-
ures 4D and 4E). Expression of gata3, another Stat3-regulated
gene involved in cell proliferation, was reduced by dex treatment
but not significantly increased by il4-6xHis overexpression (Fig-
ure 4F). Expression of stat3 itself was not altered by dex treat-
ment (Figure S6). From this regulatory role of both GCs and
IL-4 on Stat3 target genes, we hypothesized that the two
signaling pathways regulate CMmitotic activity throughmodula-
tion of Stat3 activation and thus transcription of genes governing
cell-cycle progression.
To test this hypothesis, we employed a well-characterized
dominant-negative form of Stat3 (DNStat3), carrying a tyro-
sine-to-phenylalanine mutation in the activation loop that inhibits
endogenous Stat3 signaling by competing with its receptor inter-
action (Conway, 2006) (Figures 4G–4L). Inducible expression of
DNStat3 specifically in CMs was achieved by treatment
of Tg(myl7:H2B-GFP)zf521; Tg(myl7:creER)pd10; Tg(actb2:loxP-
DsRed-loxP-DNStat3-GFP)pd59 embryos with 4-hydroxytamoxi-
fen (4-OHT) from 1 to 2 dpf (Figure 4G). Analysis of PCNA content
at 5 dpf showed that DNStat3 reduced the CM proliferative rate
compared to control siblings (Figures 4H and 4I). Importantly,
DNStat3 also abolished the increase of the proliferative rate
induced by overexpression of il4-6xHis (Figures 4H and 4I), indi-
cating that Stat3 is a crucial mediator of IL-4 mitogenic signalingin CMs. Furthermore, expression of DNStat3 in CMs abolished
the pro-mitotic effect of mif-mediated GR inhibition (Figures
4J–4L). Together, these data indicate that IL-4 and GC antago-
nistic signaling through regulation of Stat3 activity in CMs fine-
tunes cell proliferation not only in response to stressors, but
also during physiological development of the heart.
Cell-Autonomous Signaling by the GR and IL-4r in CMs
Regulates Their Proliferation
GCs are known to modulate growth hormone secretion (Maz-
ziotti and Giustina, 2013), raising the possibility that their effect
on CM proliferation might be secondary to a reduction of overall
growth rate. However, disruption of cell proliferation by modula-
tion of Stat3 activity specifically in CMs suggests cell-autono-
mous signaling of the GR and IL-4r. To test this hypothesis, we
generated a transgenic construct to express the GR specifically
in CMs. The construct harboring a mKate-GR fusion transgene,
linked by a polypeptide linker and placed downstream of the
myl7 promoter (Figure 5A), was injected into 1–2 cell-stage
Tg(myl7:H2B-GFP)zf521 embryos to achieve mosaic expression.
Analysis of PCNA contents 5 days later showed that a signifi-
cantly lower percentage of mKate-GR+ CMs entered the cell cy-
cle as compared to mKate-GR– cells in the same hearts (Figures
5D–5G and 5P), confirming the role of the GR in antagonizing
mitotic signaling in CMs. Importantly, these findings also sug-
gest that elevated GCs in response to stress suppress mitotic
activity directly through activation of the GR present in CMs
and not indirectly through growth hormone secretion.
To interfere with endogenous IL-4r signaling in CMs, we in-
jected into 1–2 cell-stage embryos a construct encoding myl7-
driven Il4r with its cytoplasmic domain truncated and fused to
the red fluorescent protein (Il4rDC-RFP; Figure 5B). The trun-
cated form lacking the cytoplasmic domain containing the Stat
docking site was shown to interfere with the endogenous IL-4r
to activate Stat-mediated gene expression (Gandhi et al.,
2014). In line with our finding of the requirement of IL-4 signalingCell Reports 33, 108404, November 17, 2020 5
Figure 4. Regulation of Myocardial Growth
by GR and IL-4 Signaling Interaction Is Medi-
ated by Stat3
(A) Bar graphs showing average fold changes of
mRNA encoding IL-4 and its receptors IL-4r, IL-
13ra1, and IL-13ra2 in 5-dpf larvae treated with dex
for 2 h.
(B–F) Graphs depicting average fold change of
mRNA transcribed from genes downstream of Stat6
(B and C) or Stat3 (D–F) in the hearts of 5-dpf wild-
type larvae exposed to dex or il4-6xHIS-over-
expressing Tg(hsp70:il4-6xHIS)md74 larvae.
(G) Schematic representation of experimental
design to obtain data shown in (H) and (I).
CM-specific expression of creER in Tg(myl7:
H2B-GFP)zf521; Tg(myl7:creER)pd10; Tg(actb2:
loxP-DsRed-loxP-DNStat3-GFP)pd59 embryos was
induced with 4-OHT treatment from 1 to 2 dpf.
Overexpression of Il4-6xHis from the hsp70:
il4-6xHis transgene was induced by exposure to
38C for 1.5 h.
(H) The 5-dpf control and DNStat3-expressing
hearts with and without il4-6xHis overexpression,
immunostained for PCNA and GFP.
(I) Bar graph depicting average percentages of
PCNA+ CMs in control, DNStat3-overexpression,
il4-6xHis-overexpression, and il4-6xHis + DNStat3-
overexpression treatment groups.
(J) Design of experiment shown in (K) and (L).
DNStat3 expression was induced as described in
(G). The GR inhibitor mif was applied at 5 dpf for 6 h
before sample fixation.
(K) PCNA and GFP immunostaining of 5-dpf control
and DNStat3-expressing hearts with and without
mif treatment.
(L) Bar graph showing average percentages of PCNA+ CMs in control, mif treatment, DNStat3-overexpression, and DNStat3-overexpression with mif treatment
groups.
Data are presented asmean ±SEM. *p < 0.05, **p < 0.01, ***p < 0.001, n.s., not significant, t test. n indicates number of samples of pooled hearts or larvae (A–F) or
number of larvae (I and L). See also Figure S6.
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that mitotic rates of Il4rDC-RFP+ CMs were lower than those of
Il4rDC– cells in 5-dpf hearts (Figures 5H–5K and 5Q). In larvae in-
jected with a control myl7:RFP plasmid, proliferation rates of
RFP+ and RFP– CMs were similar (Figures 5C, 5L–5O, and 5R).
The myl7:mKate-GR, myl7:Il4rDC-RFP, and myl7:RFP plasmids
did not induce cell death, since cells expressing the constructs
were not stained with TUNEL (Figure S7A), and we did not detect
reduced numbers of CMs expressing the transgenes between 3
and 5 dpf (Figure S7B).
Together these data strongly suggest that CM-autonomous
GR and IL-4r signaling interacts through Stat3, which is nega-
tively regulated by GR and acts as positive relay for the IL-4r.
IL-4Ra Is Indispensable for CM Proliferation in the
Developing Mouse Heart
In order to address the question of if the role of IL-4 signaling in
heart development is evolutionary conserved, we measured the
proliferative rate of CMs in the neonatal heart of mice harboring a
null mutation of the IL-4 receptor alpha (Il4ra) gene. Immuno-
staining of the cell proliferation marker Ki67—expressed during
G1-M phases—in sections of hearts of P0 Il4ra–/– mice revealed
a lower proliferation rate of CMs, identified with immunofluores-6 Cell Reports 33, 108404, November 17, 2020cent staining of the CMmarker Troponin T2 (Tnnt2), compared to
control Il4ra+/+ animals (Figures 6A and 6B). Proliferation rate
was also reduced in Il4ra+/– hearts, although it was still signifi-
cantly higher than that of Il4ra–/– mutants. Accordingly, mem-
brane labeling of CMs by wheat germ agglutinin (WGA) indicated
lower CM density in Il4ra–/– and, to a lesser extent, in Il4ra+/–
hearts (Figures 6C and 6D). CMs in Il4ra–/– mice were larger
than in Il4ra+/+ controls (Figure 6E), suggesting that the devel-
oping heart might compensate for the presence of fewer CMs
upon IL-4Ra loss with hypertrophic growth. In contrast, lack of
IL-4Ra did not alter CMs ploidy (Figures 6F and 6G). Moreover,
hearts of Il4ra+/– and Il4ra–/– mice did not show grossmorpholog-
ical alteration nor increased fibrosis (Figures 6H and 6I), suggest-
ing the requirement of IL-4 signaling specifically in CM prolifera-
tion, but not in other cardiac morphogenesis processes. These
data strongly suggest an important evolutionary conserved role
of IL-4 signaling in controlling the development of vertebrate
hearts.
GC-IL-4 Signaling Regulates Proliferation ofMouseCMs
Next, we asked if the interaction between the GC and IL-4
signaling pathways we observed in zebrafish also occurs in
mice. To this end, we quantified proliferation of cultured CMs
Figure 5. GR and IL-4r Signaling Regulate CM Proliferation Cell Autonomously
(A–C) Schemes of the transgenic constructs used in the experiment displayed in (D)–(R).
(D–O) Confocal images depicting ventricles of 5-dpf Tg(myl7:H2B-GFP)zf521 fish injected at 1–2 cell stages with plasmids containing myl7:mKate-GR (D–G),
myl7:il4rDC-RFP (H–K), or myl7:RFP (L–O) transgenes.
(P–R) Graphs depicting percentages of PCNA+ CMs either containing or not containing the mKate-GR (P) or Il4rDC-RFP (Q) recombinant proteins or RFP (R).
Data are presented as mean ± SEM. ***p < 0.001, n.s., not significant, t test. n indicates number of larvae used for experiments. See also Figure S7.
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OPEN ACCESSobtained from neonatal (P0) mice after activation of GC and/or
IL-4 pathways (Figure 7). In agreement with our results in zebra-
fish, 24 h of dex treatment after 2 days in culture reduced CM
proliferation—assessed with incorporation of the thymidine
analog 5-Ethynyl-20-deoxyuridine (EdU) applied for 12 h—
compared to control. In contrast, application of recombinant
IL-4 for 24 h resulted in higher percentages of CMs entering
the cell cycle. Similar to what we observed in vivo in zebrafish,
activation of GC signalingwith dex antagonized themitogenic ef-
fect of IL-4.
These results indicate that the modulatory role of GC-IL-4
signaling interaction on CM proliferation is an evolutionarily
conserved feature among different vertebrates.
DISCUSSION
Excessive or precocious exposure to GCs in early life retards
overall growth and increases the risk of cardiovascular disease
observed in adulthood (Seckl and Holmes, 2007). In the heart,
it was shown that GCs act via theGR to promote structural matu-
ration of the myocardium in mouse and zebrafish (Rog-Zielinska
et al., 2013; Wilson et al., 2015). Mice lacking the GR in CMs
spontaneously develop hypertrophic cardiomyopathy and die
prematurely from heart failure (Oakley et al., 2013). These studies
used pharmacological or genetic interventions (i.e., application
of exogenous GCs or mutagenesis of the GR) to interfere withstress-responsive pathways. Here, we show that brain-medi-
ated stress triggered by a physical challenge (forceful alteration
of swimming pattern) early in life has a strong influence on car-
diac development.
Our work has revealed a regulatory function of GR signaling in
CM proliferation. Excessive GR signaling disrupts physiological
growth of the myocardium through suppression of CM cell
division, leading to underdeveloped trabecular layer, cardiac
hypertrophic remodeling, and contractile dysfunction. The anti-
proliferative response of CMs and subsequent alteration of
myocardial morphology might be a mechanism by which stress
regulates developmental programming. Consequently, detri-
mental outcomes of functional alteration may culminate in car-
diovascular pathology later in life. The negative impact of GR
activation on contraction and relaxation speeds, but insignificant
effects on ejection fraction and fractional shortening of the
ventricle, imply an adaptive response of the developing heart.
Accordingly, eccentric hypertrophy, commonly associated with
fewer ventricular CM numbers (Tracy, 2013), occurred upon
GR activation. This morphological alteration is known to predis-
pose the heart to failure risk, particularly systolic dysfunction
(Gjesdal et al., 2011; Kuroda, 2015; Velagaleti et al., 2014).
Our finding that inhibition of GR signaling leads to myocardial
hyperproliferation is surprising, given the common assumption
that the stress response occurring in late development (Seckl
and Holmes, 2007) only plays a role in CM maturation (OakleyCell Reports 33, 108404, November 17, 2020 7
(legend on next page)






OPEN ACCESSet al., 2013; Rog-Zielinska et al., 2013). In fact, significantly
elevated left ventricular mass has been observed in CM-specific
GR knockout mice in the absence of fibrosis and prior to activa-
tion of hypertrophic response (Oakley et al., 2013), suggesting
the possible occurrence of myocardial hyperplasia and its caus-
ative role in these morphological and functional adversities. Our
finding calls for a better understanding of the functional implica-
tions of GR signaling in the physiological development of the
heart, extending beyond the current model implicating it only
as an adaptive response to stress. The balance of GR activity
might regulate a trade-off between proliferation and maturation
of CMs that, if perturbed, may reduce resilience to heart disease
in adulthood. Our findings reveal that finetuning the level of GR
signaling activation is, at least in part, mediated by an inter-organ
signaling crosstalk, involving the brain (HPA axis), the heart (GR
and IL-4r activation in CMs), and possibly the immune system
(IL-4 production) and orchestrating a competitive GR-IL-4 inter-
action to activate Stat3. By interfering with the GR, IL-4r, and
Stat3 activation specifically in CMs, we showed that the
signaling interaction acts directly in these muscle cells, and it
is not due to indirect effects mediated by other cell types. These
manipulations did not lead to death or evident morphological
alterations of CMs, suggesting their specificity in modulating
proliferation, although other possible subtle alterations of cell
physiology cannot be completely excluded.
Cytokines can act both locally and systemically through their
secretion by tissue-resident or recruited immune cells and diffu-
sion into circulation (Assen and Sixt, 2017; Perona-Wright et al.,
2010). Despite their accessibility to virtually all tissues and broad
biological responses, we still know little about non-immune roles
of cytokine signaling pathways. IL-4 is best known as an inducer
of Th2 response (Chen et al., 2004). It was reported that in steady
state, in the absence of infection,mice produce small quantities of
IL-4 that can be detected in the serum (Finkelman and Morris,
1999). In addition to immune cells, IL-4 was shown to be secreted
from developing skeletal muscles to attract myoblast recruitment
to promote fusion and growth (Horsley et al., 2003). In the adult
heart, IL-4 might exhibit a pro-fibrotic role. IL-4 deficiency was
linked to reduced interstitial collagen production in response to
hypertension, protecting the heart fromadverse functional remod-
eling (Kanellakis et al., 2012; Peng et al., 2015). Here, we report a
previously unrecognized role of IL-4 as a pro-mitotic signal for
CMs of the developing heart acting through the atypical signaling
transducer Stat3. This function appears to be evolutionarilyFigure 6. Mice Lacking IL-4Ra Exhibit Low CMProliferative Rate and Re
Fibrosis
(A) P0 heart sections from Il4ra+/+, Il4ra+/–, and Il4ra–/– mice, stained for the CM m
(B) Graph depicting the average percentage of Ki67+ CMs in P0 Il4ra+/+, Il4ra+/–,
(C) Images showing WGA, Tnnt2, and DAPI staining of sections from P0 Il4ra+/+,
(D) Graph depicting average WGA+/Tnnt2+ CM density.
(E) Graph depicting average CM size, measured as cell cross-section area.
(F) Representative plots showing distribution of DAPI fluorescence intensities in
Il4ra–/– heart. The fluorescence intensity ranges used for determining diploid (2n)
(G) Graph showing average percentage of diploid (2n) CMs in Il4ra+/– and Il4ra–/–
(H) Sections fromP0 Il4ra+/+, Il4ra+/–, and Il4ra–/– hearts stained withMasson’s trich
ventricular wall; LVW, left ventricular wall; IVS, intra-ventricular septum.
(I) Graph showing average ventricular wall thickness (quantified as percentage o
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, n.s., notconserved in vertebrates, since we observed its requirement
and interaction with the GC signaling pathway in both zebrafish
and mouse. The fact that IL-4 is known to be secreted by immune
cells, togetherwith our data showing strongexpressionof il4 in the
thymus of zebrafish larvae, suggests that the source of IL-4 acting
on heart development may be cells of the immune system.
However, with the tools used in this work, we could not pinpoint
a direct role of immune-cells-derived IL-4 in cardiac development.
An approach using cell-type-specific loss-of-function of il4will be
required to unambiguously prove an involvement of the immune
system. The GC and IL-4 signaling interaction identified here
differs from the well-known immunosuppressive action of cortico-
steroids through inhibition of cytokine production (Cain and
Cidlowski, 2017). We did not detect changes in the expression
of IL-4 signalingmolecules including the ligand itself, its receptors,
or stat3 in response to alteration of GR signaling. Instead, we
showed that a fine balance of GR and IL-4 signaling regulates
CM Stat3 activation and thereby transcriptional activity of several
Stat3 target genes that serve as key mediators of the cell-
cycle machinery. While the stress response—through activation
of the GR—leads to suppression of CM proliferation, at the
cost of morphological alteration and contractile dysfunction,
GR activity may be required to maintain physiological growth
rate of the myocardium by balancing the level of activated
Stat3 in CMs. On the other hand, IL-4 could counterbalance GR
hyperactivation and restore CM mitotic activity through competi-
tive activation of Stat3. In line with our finding, Stat3 has been
shown to play a key role in cell-cycle reentry of matured mamma-
lian CMs, a hallmark of cardiac regeneration (Miyawaki et al.,
2017). Thus, our work suggests that activated Stat3 represents
a potential target for the prevention/reversion of cell-cycle exit
and terminal differentiation of CMs upon exposure to early-life
stress.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
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Figure 7. GR and IL-4 Signaling Interact to Regulate Proliferation of
Mouse CMs.
(A) Schemes showing timeline of control, dex, IL-4 (green bar), and EdU (red
bar) treatments.
(B) Images of cultured neonatal (P0) mouse CMs treated with control solution,
dex, IL-4, and dex plus IL-4 combinatorial exposure. CMs were immuno-
stained with an antibody against Tnnt2 (green). Proliferating cells were labeled
by DNA incorporation of EdU (purple), and cell nuclei were stained with DAPI
(blue).
(C) Bar graph depicting average percentage of EdU+ CMs exposed to different
combinations of GR (dex) and IL-4 signaling activation.
Data are presented as mean ± SEM. *p < 0.05, ***p < 0.001, t test. n indicates
number of biological replicates.
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Antibodies
monoclonal mouse anti human IL4 antibody R&D systems Cat# MAB204; RRID: AB_2126745
monoclonal mouse 6X-HIS antibody Invitrogen Cat# MA1-21315; RRID: AB_557403
polyclonal chick anti-GFP Thermo Fisher Cat# A10262; RRID: AB_2534023
polyclonal rabbit RFP MBL Cat# PM005; RRID: AB_591279
monoclonal mouse Anti-Proliferating Cell Nuclear
Antigen (PCNA)
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monoclonal mouse anti cardiac Troponin T2 Abcam Cat# ab33589; RRID: AB_727035
polyclonal rabbit Anti-Ki-67 Antibody Millipore Cat# AB9260; RRID: AB_2142366
Alexa Fluor 488 Anti-chicken Thermo Fisher Cat# A-11039; RRID: AB_142924
Alexa Fluor 647 Anti-mouse Cell Signaling Cat# 4410S; RRID: AB_1904023
Alexa Fluor 555 Anti-rabbit Cell Signaling Cat# 4413; RRID: AB_10694110
Alexa Fluor 488 Anti-rabbit Cell Signaling Cat# 4412; RRID: AB_1904025
Alexa Fluor 488 Anti-mouse Cell Signaling Cat# 4408S; RRID: AB_10694704
Biological Samples
Cardiomyocytes from P0 C57BL/6N mice MDC animal facility N/A
Chemicals, Peptides, and Recombinant Proteins
Wheat germ agglutinin-conjugated CF555 Biotium Cat# 29076-1
Dexamethasone Sigma Cat# D1756
Miferpristone Sigma Cat# M8046
4-hydroxytamoxifen (4-OHT) Sigma Cat# H7904
TRIzol Life Technologies Cat# 15596026
Trypsin-EDTA Sigma Cat# T4049
Trypsin GIBCO Cat# 15090046
DNaseI Roche Cat# 10104159001
Dulbecco’s Modified Eagle Medium, high glucose,
GlutaMAX
GIBCO Cat# 31966021
Fetal Bovine Serum GIBCO Cat# 10270106
Penicillin-Streptomycin (10.000 U/ml) Thermo Fisher Cat# 15140122
Fibronectin Bovine Protein, Plasma Thermo Fisher Cat# 33010-018
dexamethasone- suitable for cell culture Sigma Cat# D4902
recombinant murine IL4 PeproTech Cat# 214-14
Liberase TL Research Grade Roche Cat# 5401020001
Pluron F-68 polyol, 100 ml MP Biomedicals Cat# 092750049
Critical Commercial Assays
Click-iT EdU imaging kit Thermo Fisher Cat# C10640
Click-iT TUNEL Alexa Fluor 647 Thermo Fisher Cat# C10247
Masson’s trichrome staining kit Roche Cat# 860-031
Cold Fusion Cloning Kit System Biosciences Cat# MC010A-1
SuperScript III First Strand Kit Life Technologies Cat# 18080051
Luna Universal qPCR Master Mix New England BioLabs Cat# M3003
Experimental Models: Organisms/Strains
Zebrafish: Tg(myl7:Cre-ERT2)pd12 Kikuchi et al., 2010 ZFIN: ZDB-ALT-110307-1
Zebrafish: Tg(myl7:mKate-CAAX)sd11 Lin et al., 2012 ZFIN: ZDB-ALT-120320-1
Zebrafish: Tg(myl7:H2B-GFP)zf521 Mickoleit et al., 2014 ZFIN: ZDB-ALT-071120-1
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Zebrafish: Tg(actb2:loxP-DsRed-loxP-dnstat3 EGFP)s928 Fang et al., 2013 ZFIN: ZDB-ALT-110210-11
Zebrafish: Tg(myl7:GAL4)s740 Sawamiphak et al., 2017 ZFIN: ZDB-ALT-180427-1
Zebrafish: Tg(myl7:GFP)f1 Burns et al., 2005 ZFIN: ZDB-ALT-060719-2
Zebrafish: TgBAC(csf1ra:GAL4-VP16)i186 Gray et al., 2011 ZFIN: ZDB-ALT-110707-2
Zebrafish: Tg(UAS-E1B:NTR-mCherry)c264 Davison et al., 2007 ZFIN: ZDB-ALT-070316-1
Zebrafish: Tg(kdrl:Hsa.HRAS-mCherry)s896 Chi et al., 2008 ZFIN: ZDB-ALT-081212-4
Zebrafish: Tg(fli:nls-mcherry)ubs10 Heckel et al., 2015 ZFIN: ZDB-ALT-160726-2
Zebrafish: Tg(wt1b:EGFP)li1 Perner et al., 2007 ZFIN: ZDB-ALT-071127-1
Zebrafish: Tg(hsp70l:il4-6XHIS)md74 This paper N/A
Mice: BALB/c-Il4ratm1Sz/J Noben-Trauth et al., 1997,
Jackson Laboratory
Stock No: 003514
Mice: C57BL/6N MDC animal facility N/A
Oligonucleotides
See Table S1 N/A
Recombinant DNA
myl7:RFP This paper N/A
myl7:il4rDC-RFP This paper N/A
myl7:mKate-GR This paper N/A
Software and Algorithms
Fiji/ImageJ NIH https://fiji.sc/
Imaris Oxford Instruments https://imaris.oxinst.com/
Prism GraphPad Software https://www.graphpad.com/scientific-
software/prism/







Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, Suphansa
Sawamiphak (Suphansa.Sawamiphak@mdc-berlin.de).
Materials Availability
Plasmids and zebrafish lines generated in this study are available upon request.
Data and Code Availability
Raw data described in this study are available upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal husbandry was performed under standard conditions, and experiments were conducted in accordance with institutional (Max
Delbr€uck Center for Molecular Medicine), State (LAGeSo Berlin), and German ethical and animal welfare guidelines and regulations.
Sex of zebrafish and mice cannot be determined at the developmental stages considered in this study. Animals were randomly as-
signed to experimental groups.
Zebrafish
All zebrafish experiments were performed on larvae up to 5 dpf. Previously established transgenic zebrafish lines used for this study
include Tg(myl7:Cre-ERT2)pd12 (Kikuchi et al., 2010), Tg(myl7:mKate-CAAX)sd11 (Lin et al., 2012), Tg(myl7:H2B-GFP)zf52 (Mickoleit
et al., 2014), Tg(myl7:GAL4)s740 (Sawamiphak et al., 2017), Tg(actb2:loxP-DsRed-loxP-dnstat3 EGFP)s928 (Fang et al., 2013),
TgBAC(csf1ra:GAL4-VP16)i186 (Gray et al., 2011), Tg(UAS-E1B:NTR-mCherry)c264 (Davison et al., 2007), Tg(kdrl:Hsa.HRAS-
mCherry)s896 (Chi et al., 2008), Tg(myl7:GFP)f1 (Burns et al., 2005), Tg(fli:nls-mcherry)ubs10 (Heckel et al., 2015), Tg(wt1b:EGFP)li1
(Perner et al., 207). To generate the Tg(hsp70l:il4-6XHIS)md74 line, we first amplified il4 open reading frame and added 6xHIS epitopee2 Cell Reports 33, 108404, November 17, 2020
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OPEN ACCESSsequence to its C terminus by PCR from a cDNA library generated from 54 hpf zebrafish embryos. The il4-6xHIS fragment was then
cloned downstream of a hsp70l promoter in a vector containing a cryaa:Cerulean expression cassette and I–SceI recognition sites.
The construct was injected into one-cell stage embryos together with I-SceI meganuclease to enable genomic integration of the
transgene. Injected embryos were sorted for Cerulean expression in the lens and raised to adulthood. Identified founders were out-
crossed and offspring were raised and expanded.
Phenylthiourea (PTU) was applied to zebrafish starting from 1 dpf to block skin pigmentation.
Mice
BALB/c-Il4ratm1Sz/J (Noben-Trauth et al., 1997) mice were obtained from the Jackson Laboratory. Mice were genotyped by PCRwith
three primers (Il4ra_wt: TGTGGGCTCAGAGTGACCAT; Il4ra_mut: CCAGACTGCCTTGGGAAAAG; Il4ra_common: CAGGGAA
CAGCCCAGAAAAG) which leads to amplification of 441 bp (wild-type allele) and 247 bp (mutant allele) DNA fragments. Postnatal
(P0) C57BL/6N mice were used to obtain cardiomyocytes for cell cultures.
METHOD DETAILS
Generation of expression constructs
To generate the dominant negative form of zebrafish il4r, we amplified il4r lacking the cytoplasmic domain (il4rDC) from a zebrafish
cDNA library and cloned it downstream of myl7 promoter in a pTol2 vector containing RFP using NheI and NcoI sites. Primers used
are NheI-kozak-il4r.F: GATTGCTAGCGCCGCCACCATGAAGTTCAATGTTTCGTTT and NcoI-il4rdeltaC.R: GACACCATGGCC
AAAAAACAGATGAAGGTCAT
Zebrafish GR (zGR) was amplified from PCS2+zGRa plasmid (Schaaf et al., 2008). The zGR gene fused to a sequence encoding
Gly-Gly-Gly-Gly-Ser linker sequence and mKate was then inserted downstream of myl7 promoter in the pTol2 vector using Cold
Fusion Cloning Kit (System Biosciences). To generate the myl7:RFP construct, the myl7 promoter and the RFP coding sequence
were amplified and cloned into pTol2 vector using the Cold Fusion Cloning Kit (System Biosciences). Zebrafish embryos at one-
cell stage were injected either with myl7:mKate-GR, myl7:il4rDC-RFP, or myl7:RFP constructs. Each Injected fish were live imaged
at day 3 and day 5. Cardiomyocyte proliferation was analyzed at 5 dpf. Apoptosis of cardiomyocytes was analyzed at 3dpf.
Gene expression by heat-induction and treatments with drug and neutralizing antibody
For heat induction of il4-6xHis expression, embryoswere transferred into awater bath preheated at 38Cand kept at this temperature
for 1.5 h. Larvae were bathed with 100 mM dexamethasone (Sigma), or 10 mMmiferpristone (Sigma), plus 0.5% DMSO in Danieau’s
medium (58mMNaCl, 0.7mMKCl, 0.4mMMgSO4$7H2O, 0.6mMCa(NO3)2, 5mMHEPES inwater) at desired stages and for specific
periods of time as indicated in the text. A solution of 0.5% DMSO in Danieau’s buffer was used as control.
To activate Cre-ERT2, 1 dpf old zebrafish embryos were treated with ethanol-stocked 4-hydroxytamoxifen (4-OHT, Sigma) diluted
in Danieau’s buffer to a final concentration of 6 mM. After 24 h drug was washed out and embryos were kept in fresh Danieau’s
solution until 5 dpf.
Neutralizing antibody for IL4 (IL4-nAB) (Novus Biological, MAB204) was reconstituted at 0.5 mg/ml in PBS, and 2 ml (10 mg/ml) IL4-
nABwas injected intrapericardially. A solution containing 10 mg/ml anti-6X-HIS antibody (Invitrogen, MA1-21315) in PBSwas injected
as control.
Stress treatment
4 dpf larvae were shaken for periods of 1 h duration at 300 rpm, alternated by 1 h-long intervals without shaking. The whole treatment
lasted 16 h and was performed overnight. Control larvae were maintained in similar conditions, but in the absence of shaking. After-
ward, larvae were stored in TRIzol at80C for RNA extraction, or fixed with 4%paraformaldehyde (PFA) for 2 h at room temperature
for immunostaining.
Immunofluorescent and TUNEL staining
Larvae were fixed with 4% PFA + 0.3% triton at 4C overnight, washed with PBS buffer containing 0.3% (V/V) Triton (PBST). An inci-
sion in the pericardium was performed to allow best accessibility of antibodies to the heart. Larvae were then kept in 100%methanol
at20C for at least 2 h before proceeding to staining. To improve antibody penetration, larvae were incubated with a 1:20 dilution of
Trypsin-EDTA (500 BAEE units, Sigma, T4200) in PBST on ice for 35 min followed by antigen retrieval with 150 mM tris-HCl, pH 9 at
room temperature for 5 min and then at 70C for 15 min. Then, larvae were incubated at room temperature for 1 h in blocking buffer
(PBS supplemented with 0.3% (V/V) Triton X-100, 1% DMSO, 5% (v/v) goat serum, 1% (w/v) bovine serum albumin (BSA)), followed
by primary antibodies diluted in blocking buffer for 72 h at 4C. After washing with PBST, samples were incubated with Alexa Fluor
488 Goat Anti-chicken (1:1000, ThermoFisher, A10262), Alexa Fluor 647 anti-mouse (1:500, Cell Signaling, 4410S), Alexa Fluor 555
Anti-rabbit (1:750, Cell Signaling, 4413) in blocking solution for 48 h at 4C, washed with PBST andmounted in Fluoromount aqueous
mounting medium (Sigma) for imaging. Primary antibodies are chicken anti-GFP (1:1000, ThermoFisher, A10262), rabbit polyclonal
RFP (1:500, MBL, PM005), and mouse Anti-Proliferating Cell Nuclear Antigen (PCNA) (1:300, Dako, M0879).Cell Reports 33, 108404, November 17, 2020 e3
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OPEN ACCESSCardiomyocyte apoptosis was detected by the TdT-mediated dUTPNick-End Labeling (TUNEL) technique using a Click-iT TUNEL
Alexa Fluor 647 kit (Invitrogen, C10247) according to manufacturer’s protocol. Briefly, fixed larvae were incubated in TdT reaction at
37C for 3 h followed by incubation in the Click-iT reaction at room temperature and protected from light for 1 h. For positive control,
larvae were treated with DNase I solution for 30 min at room temperature. Immunostaining using anti-GFP and anti-RFP antibodies,
described above, was performed to label cardiomyocyte nuclei.
Image analyses
To quantify proliferating and apoptotic cardiomyocytes, all single-plane images from confocal stacks that covered the entire cardiac
ventricle or atriumwere analyzed. Cells showing PCNA-labeled nuclei that were co-localized with H2B-GFPwere counted in ImageJ.
Total cardiomyocyte numbers and endocardial cell numbers were quantified using Imaris software (Oxford Instruments). Epicardial
cell numbers were counted in ImageJ. Ventricular volume was calculated using Volumest plugin in ImageJ. Trabecular and compact
wall cardiomyocytes were counted from confocal z stacks with 10 mm intervals. A total thickness of 40 mm of the ventricle was
quantified for each heart. Both membrane and nuclear makers were used to distinguish individual cardiomyocytes. Cell volume
was quantified using ImageJ.
Mouse histological and immunofluorescence analyses
Neonatal (P0) hearts were dissected, rinsed with PBS, and fixed overnight with 4% PFA in PBS at 4C. After washing in PBS, hearts
were embedded in paraffin. 7 mm-thick sections were used for immunofluorescence staining of the cardiomyocyte marker Tnnt2
(Anti-Troponin T2, Cardiac Type antibody, Abcam, ab33589), and proliferation marker Ki67 (Anti-Ki-67 Antibody, Millipore,
AB9260). After deparaffinization and rehydration, antigen retrieval was done with citrate buffer (10 mM citric acid, 0,05% Tween
20, pH 6) 15 min in a microwave. Then sections were blocked for 1 hour at room temperature with a solution of 3% BSA, 5%
goat serum, 0.3% Tween 20 in PBS. Sections were incubated overnight at 4C with primary antibodies (1:200 Tnnt2, 1:100 Ki67)
in blocking solution. Subsequently, sections were rinsed and incubated with Alexa Fluor-conjugated secondary antibodies (1:500
anti-mouse Alexa647, Cell Signaling 4410S, 1:500 anti-rabbit Alexa488, Cell Signaling 4412) for 1 hour at room temperature. Finally,
sections were treated with 1% hydrogen peroxide for 20 min at room temperature. Mounted sections were examined with a Zeiss
LSM880 NLO confocal microscopy system. 25000 square micron areas from each section were used for quantification of Tnnt2+/
Ki67+ double positive cells. Masson’s trichrome staining was performed according to the manufacturer’s instruction (Roche 860-
031). Ventricular wall and total ventricular areas were measured with ImageJ software.
Wheat germ agglutinin (WGA) staining was performed simultaneously with secondary antibodies step of immunofluorescent stain-
ing. Slides were incubated overnight at 4Cwith 1:200 dilution of WGA (WGA-conjugated CF555, Biotium, 29076-1). Cardiomyocyte
density was determined by counting of Tnnt2+/WGA+ double positive cells. Four fields of each section were examined for quantifi-
cation. In order to quantify cell size; cardiomyocyte cross sectional area was measure in ImageJ. One hundred twenty cardiomyo-
cytes with a nucleus centrally located were analyzed per each experimental group.
In situ hybridization
In situ hybridization for the assessment of il4, il4r, ifng1, and ifngr1 expression was performed as described earlier (Sawamiphak et al.,
2014). Probes were generated by PCR amplification of a 54 hpf cDNA library. Primers used were:
IL4.F: ATGAAGACCTGAAGATCTCAACATCTGGATACATC
IL4R.F: GTTTCGTTTGCGAATAGGGAAGCAG








5 dpf larvae, which were either daily exposed to 38C to induce il4-6xHis expression or dexamethasone treated from 2 to 5 dpf, were
embedded in 2% low-melting-point agarose. The ventricles were imaged with a transmitted light microscope equipped with a 40X
objective and a high-speed camera (Ximea). 10 s-long movies were acquired at 300 frames per second.
To calculate diastolic and systolic speed, areas of the heart at the end of a diastole and of a systole were measured in Fiji.
Area change by time was calculated as diastolic or systolic speed. Width of the ventricle at the maximum ventricular diastole
(widthVD) and ventricular systole (widthVS) were measured in Fiji and ventricular fractional shortening (FS) was calculated as
[100 x (widthVD – widthVS)/widthVD]. Ejection fraction (EF) was evaluated from ventricular volume at the end of diastole
(volumeVD) and systole (volumeVS). We first measured ventricular width and length at the end of diastole (widthVD and lengthVD)
and systole (widthVS and lengthVS) using Fiji. Then the volumeVD and volumeVS were calculated as [p x lengthVD x widthVD
2)/6]e4 Cell Reports 33, 108404, November 17, 2020
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2)/6], respectively. Finally, EF was calculated as [100 x (volumeVD – volumeVS)/volumeVD] (Yalcin
et al., 2017).
Real-time PCR
5 dpf larvaewere treatedwith 100 mMdexamethasone for 2 h, or exposed to 38C for 1.5 h to induce il4-6xHis expression, followed by
2 h recovery at room temperature. Next, hearts were dissected and collected in PBS immediately and then stored in TRIzol at80C
until usage. Total RNA was isolated from pooled whole zebrafish larvae (50) or isolated hearts (250-300) with TRIzol reagent (Life
Technologies) according to manufacturer’s instructions. 2 mg of RNA was reverse-transcribed using the SuperScript III First Strand
Kit (Life Technologies). Real-time PCR was performed using Luna Universal qPCR Master Mix (New England BioLabs) and run on a
StepOnePlus Real-Time PCR System (Applied Biosystems). Samples were analyzed using 2-DDCt method (Gibson et al., 1996). The
housekeeping gene gapdh was used for normalization.
PRIMERS USED IN THE EXPERIMENT AREbcl2l1: forward GCAGATTGTGTTATGGGTATGAGC, reverse GGTTGCAGGGGTAGTTCCTC
c-myc: forward GGCAGCGATTCAGAAGATGAAG, reverse CCGTCTCGTGCCTTTTCTGT
cyclinD1: forward GCCAAACTGCCTATACATCAG, reverse TGTCGGTGCTTTTCAGGTAC
gapdh: forward GTGGAGTCTACTGGTGTCTTC, reverse GTGCAGGAGGCATTGCTTACA
gata3: forward CCTGCGGACTTTACCACAAG, reverse ACAGTTTGCGCATGAGGTC
il4: forward CTGTTGGTACTTACATTGGTCCCC, reverse AGTGTCCTGTCTCATATATGTCAGGT
il4r: forward AGCAGCCAGCAGACTGAAAT, reverse ATGGGATCGTCACAAAGTGCT
il13ra1: forward GCATGTCAGAGCTTCCTCCG, reverse AGACCTTGTTGGTGGCAACT
il13ra2: forward GAGCGATGGAGGAGTGTTCG, reverse ATTGGTACAGGCGCACTTCA
socs1a: forward GCGCTCTGAGGAAACCTCTA, reverse GAGACTCATCGGTCGTTTTAGT
stat3: forward GGACTTCCCGGACAGTGAG, reverse ATCGCTTGTGTTGCCAGAGMouse cardiomyocyte isolation, culture and immunocytochemistry
Postnatal day 0 C57BL/6N pups were used for cultivation of neonatal cardiomyocytes which were prepared with slight modi-
fications according to an established protocol (Fu et al., 2005). After dissection of hearts, cells were dissociated by repeated
enzymatic digestion (0.08% trypsin in PBS, GIBCO 15090046; plus 50 mg/ml DNaseI, Roche 10104159001) and cultivated in
DMEM, high glucose, GlutaMAX supplement (GIBCO, 31966021) supplemented with 10% fetal calf serum (GIBCO, 10270-
106) and Penicillin-Streptomycin (10.000 U/ml) (Thermo Fisher, 15140122) at 37C in 95% air/5% CO2. Cells were plated
(100 ml suspension per coverslip) on glass coverslips (12 mm in diameter) pre-coated with 10 mg/ml bovine plasma fibronectin
(Thermo Fisher, 33010-018) to obtain a dense monolayer of cardiomyocytes (the density varied from preparation to preparation,
range 0.6x105 to 3.1x105 per coverslip, due to a variable contamination with erythrocytes). After attachment, additional medium
was added and cells were allowed to grow for additional 24 hours. Then, cells were treated with ethanol as a vehicle control,
100nM dexamethasone (Sigma, D4902), 10 ng/ml recombinant murine IL4 (PeproTech, 214-14), or dexamethasone (100 nM)
plus recombinant IL4 (10ng/ml) in serum free medium for 24 hours. Cells were incubated with 2 mM EdU for the last 12 h before
fixation.
After treatments, cells were washed with PBS and fixed with 4% PFA in PBS followed by 20 minutes permeabilization with Triton
X-100 (0.1%). Cells were then incubated with blocking solution (PBS supplemented with 1% BSA, 5% goat serum, and 0.1% Triton
X-100) for 1 hour, followed by incubation with primary antibody (1:300 mouse cardiomyocyte marker Tnnt2, Anti-Troponin T2,
Abcam, ab33589) overnight at 4C. After washing, cells were incubated with Alexa Fluor secondary antibody (1:1000 goat anti mouse
Alexa488, cell signaling 4408S). EdU staining was performed usingClick-iT EdU imaging kit (Thermo Fisher, C10640) according to the
manufacturer’s protocol. Cell nuclei were stained with DAPI (1 mg/ml). Mounted coverslips were imaged with a Zeiss LSM880
confocal microscopy system. Analysis was performed using ImageJ software.
Flow cytometry and polyploidy analysis
Nuclear ploidy was determined using flow cytometry. Dissociated cardiomyocytes were fixed with 4% PFA in PBS for 10 min.
Cells were then incubated with blocking solution (PBS supplemented with 2% BSA) for 1 hour, followed by incubation with primary
antibody (1:200 mouse cardiomyocyte marker Tnnt2, Anti-Troponin T2, Abcam, ab33589) for 2 hours at room temperature. After
washing three times with PBS, cells were incubated with Alexa Fluor secondary antibody (1:500 goat anti mouse Alexa488,
Cell Signaling 4408S). The nuclei were stained with DAPI (1 mg/ml). Intensity of DAPI fluorescence in nuclei of Tnn2-positive
cardiomyocytes was measured with a flow cytometer (FACS Aria II, BD Biosciences), and analysis was performed using FlowJo
10.6.2 software.Cell Reports 33, 108404, November 17, 2020 e5
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Statistical significance, with the exception of qPCR data and data shown in Figure S7B, was determined using two-tailed Student’s
t tests in Graphpad Prism. For data shown in Figure S7B one-sample Student’s t tests were used. When performing multiple
comparisons, p values were corrected using the Holm-Bonferroni method.
For real-time PCR data, statistical significance was determined with one-sample Student’s t tests, and p values were adjusted for
multiple comparisons using the Benjamini-Hochberg procedure. Outliers in real-time PCR datasets were removed after detection
with Dixon’s test.
Differences were considered statistically significant if p < 0.05. Unless otherwise stated, n indicates the number of animals used for
experiments.e6 Cell Reports 33, 108404, November 17, 2020
